Stay up to date with the latest breaking news, analysis and commentary on Mirae Asset Sharekhan. Find live updates, exchanges, stock news, earning news and more.
Marksans Pharma announced that its wholly owned subsidiary Relonchem Ltd in UK has received Marketing Authorization for the below-mentioned products from UK MHRA:
1. Clonidine 100 microgram Tablets.
2. Clonidine Hydrochloride 25 microgram Tablets.
Bharat Rasayan board to consider stock spilt & bonus issue on October 24
20 Oct 2025, 1:37PMRPP Infra bags order worth Rs. 126 cr for civil works of defence staff at NADFM, Pune
20 Oct 2025, 11:15AMVascon Engineers gets LoI for redevelopment Project worth Rs. 162 cr in Mahalaxmi, Mumbai
09-10-2025 13:37:09Indian markets settle in red taking a U-turn from morning highs.
08-10-2025 16:34:49Memorandum of Understanding (MOU) with the Ministry of Food Processing Industries (MoFPI), Government of India
03-10-2025 13:03:18Budget 2024 Analysis
